0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-5Q2346
Home | Market Reports | Arts & Entertainment
Global Non steroidal Anti inflammatory Drugs NSAID Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2023

Code: QYRE-Auto-5Q2346
Report
February 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market

The global Non-steroidal Anti-inflammatory Drugs (NSAID) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Non-steroidal Anti-inflammatory Drugs (NSAID) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-steroidal Anti-inflammatory Drugs (NSAID), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-steroidal Anti-inflammatory Drugs (NSAID).
The Non-steroidal Anti-inflammatory Drugs (NSAID) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-steroidal Anti-inflammatory Drugs (NSAID) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Bayer
  • Ecotrin
  • Generic
  • St. Joseph
  • Elanco
  • Zoetis
  • Boehringer Ingelheim
  • Merial
  • Merck Animal Health

Segment by Type

  • Salicylates
  • Propionic acid derivatives
  • Acetic acid derivatives
  • Enolic acid (Oxicam) derivatives
  • Anthranilic acid derivatives (Fenamates)
  • Selective COX-2 inhibitors (Coxibs)
  • Sulfonanilides

Segment by Application

  • Human
  • Animals
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report

Report MetricDetails
Report NameGlobal Non-steroidal Anti-inflammatory Drugs (NSAID) Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2023-2029)
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value by Application: (2023-2029)
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts
1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2018-2029
1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2018-2029
1.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2018-2023)
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application
2.7 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends
2.7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players Market Share by Revenue
2.7.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario by Region
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2018-2029
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2018-2023
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region: 2024-2029
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2018-2029
3.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2018-2023
3.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2024-2029
3.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.4.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2029)
3.4.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.5.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2029)
3.5.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.7.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2029)
3.7.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2018-2029)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2018-2023)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2024-2029)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2018-2029)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2018-2029)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2018-2023)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2024-2029)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2018-2029)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2018-2029)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2018-2023)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2024-2029)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2018-2029)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2018-2029)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2018-2023)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2024-2029)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2018-2029)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Ecotrin
6.2.1 Ecotrin Corporation Information
6.2.2 Ecotrin Description and Business Overview
6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.2.5 Ecotrin Recent Developments/Updates
6.3 Generic
6.3.1 Generic Corporation Information
6.3.2 Generic Description and Business Overview
6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.3.5 Generic Recent Developments/Updates
6.4 St. Joseph
6.4.1 St. Joseph Corporation Information
6.4.2 St. Joseph Description and Business Overview
6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.4.5 St. Joseph Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Zoetis
6.6.1 Zoetis Corporation Information
6.6.2 Zoetis Description and Business Overview
6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.6.5 Zoetis Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Merial
6.8.1 Merial Corporation Information
6.8.2 Merial Description and Business Overview
6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.8.5 Merial Recent Developments/Updates
6.9 Merck Animal Health
6.9.1 Merck Animal Health Corporation Information
6.9.2 Merck Animal Health Description and Business Overview
6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Portfolio
6.9.5 Merck Animal Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis
7.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing
7.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels
7.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
7.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
8 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Dynamics
8.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
8.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Non-steroidal Anti-inflammatory Drugs (NSAID), Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Product Type & Application
    Table 12. Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID), Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2018-2023) & (K Units)
    Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2018-2023)
    Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2024-2029) & (K Units)
    Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2024-2029)
    Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2018-2023)
    Table 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2024-2029)
    Table 25. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
    Table 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
    Table 28. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2018-2023)
    Table 51. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2024-2029)
    Table 52. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2018-2023)
    Table 53. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2024-2029)
    Table 54. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2018-2023)
    Table 57. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2024-2029)
    Table 58. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2018-2023)
    Table 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2024-2029)
    Table 62. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2018-2023)
    Table 63. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2024-2029)
    Table 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2018-2023)
    Table 67. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2024-2029)
    Table 68. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2024-2029)
    Table 70. Bayer Corporation Information
    Table 71. Bayer Description and Business Overview
    Table 72. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 74. Bayer Recent Developments/Updates
    Table 75. Ecotrin Corporation Information
    Table 76. Ecotrin Description and Business Overview
    Table 77. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 79. Ecotrin Recent Developments/Updates
    Table 80. Generic Corporation Information
    Table 81. Generic Description and Business Overview
    Table 82. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 84. Generic Recent Developments/Updates
    Table 85. St. Joseph Corporation Information
    Table 86. St. Joseph Description and Business Overview
    Table 87. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 89. St. Joseph Recent Developments/Updates
    Table 90. Elanco Corporation Information
    Table 91. Elanco Description and Business Overview
    Table 92. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 94. Elanco Recent Developments/Updates
    Table 95. Zoetis Corporation Information
    Table 96. Zoetis Description and Business Overview
    Table 97. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 99. Zoetis Recent Developments/Updates
    Table 100. Boehringer Ingelheim Corporation Information
    Table 101. Boehringer Ingelheim Description and Business Overview
    Table 102. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 104. Boehringer Ingelheim Recent Developments/Updates
    Table 105. Merial Corporation Information
    Table 106. Merial Description and Business Overview
    Table 107. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 109. Merial Recent Developments/Updates
    Table 110. Merck Animal Health Corporation Information
    Table 111. Merck Animal Health Description and Business Overview
    Table 112. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product
    Table 114. Merck Animal Health Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
    Table 118. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
    Table 119. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
    Table 120. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
    Table 121. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
    Table 122. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
    Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2022 & 2029
    Figure 4. Salicylates Product Picture
    Figure 5. Propionic acid derivatives Product Picture
    Figure 6. Acetic acid derivatives Product Picture
    Figure 7. Enolic acid (Oxicam) derivatives Product Picture
    Figure 8. Anthranilic acid derivatives (Fenamates) Product Picture
    Figure 9. Selective COX-2 inhibitors (Coxibs) Product Picture
    Figure 10. Sulfonanilides Product Picture
    Figure 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2022 & 2029
    Figure 13. Human
    Figure 14. Animals
    Figure 15. Others
    Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size (2018-2029) & (US$ Million)
    Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (2018-2029) & (K Units)
    Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) & (2018-2029)
    Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
    Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers in 2022
    Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers in 2022
    Figure 23. The Global 5 and 10 Largest Non-steroidal Anti-inflammatory Drugs (NSAID) Players: Market Share by Revenue in 2022
    Figure 24. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
    Figure 27. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
    Figure 28. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
    Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
    Figure 32. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2018-2029)
    Figure 38. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2018-2029)
    Figure 39. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
    Figure 50. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
    Figure 51. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2018-2029)
    Figure 55. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2018-2029)
    Figure 56. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2018-2029)
    Figure 60. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2018-2029)
    Figure 61. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2018-2029)
    Figure 62. Global Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2018-2029)
    Figure 63. Global Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2018-2029)
    Figure 64. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Application (2018-2029)
    Figure 65. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain
    Figure 66. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS